Doximity Stock News

Doximity, Inc. (NASDAQ:DOCS) Equities research analysts at Jefferies Financial Group issued their Q3 2022 earnings estimates for Doximity in a report released on Wednesday, December 1st. Jefferies Financial Group analyst G. Santangelo expects that the company will post earnings per share of $0.16 for the quarter. Jefferies Financial Group has a Buy rating and [] The post Jefferies Financial Group Weighs in on Doximity, Inc.s Q3 2022 Earnings (NASDAQ:DOCS) appeared first on ETF Daily News .

Zacks Investment Research cut shares of Doximity (NASDAQ:DOCS) from a buy rating to a hold rating in a research report sent to investors on Thursday morning, Zacks.com reports. According to Zacks, Doximity Inc. provides digital platform for medical professionals. The companys network members include physicians across all specialties and practice areas. It provide its verified [] The post Zacks Investment Research Downgrades Doximity (NASDAQ:DOCS) to Hold appeared first on ETF Daily News .

Jefferies Financial Group assumed coverage on shares of Doximity (NASDAQ:DOCS) in a report released on Wednesday morning, PriceTargets.com reports. The brokerage issued a buy rating and a $78.00 price objective on the stock. A number of other analysts have also weighed in on DOCS. Needham & Company LLC upped their price objective on Doximity from []

Shares of Doximity, Inc. (NASDAQ:DOCS) gapped down prior to trading on Friday . The stock had previously closed at $67.51, but opened at $65.29. Doximity shares last traded at $62.23, with a volume of 14,154 shares. A number of equities research analysts have issued reports on DOCS shares. Canaccord Genuity increased their target price on []

Central Bank & Trust Co. acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 600 shares of the companys stock, valued at approximately $48,000. A number of other institutional investors []

Doximity (NASDAQ:DOCS) and Perion Network (NASDAQ:PERI) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and recommmendations for Doximity and Perion Network, as []

Doximity Inc. (NYSE:DOCS) has seen 3.26 million shares traded in the last trading session. The company, currently valued at $13.57B, closed the last trade at $67.65 per share which meant it gained $0.98 on the day or 1.47% during that session. The DOCS stock price is -59.33% off its 52-week high price of $107.79 and Doximity Inc. (DOCS): What Makes The Stock Good? Read More »

Doximity, Inc. (NASDAQ:DOCS) rose 5.1% during trading on Monday . The stock traded as high as $66.68 and last traded at $64.26. Approximately 69,370 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 2,305,598 shares. The stock had previously closed at $61.13. DOCS has been the topic of []

Perion Network (NASDAQ:PERI) and Doximity (NASDAQ:DOCS) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Profitability This table compares Perion Network and Doximitys net margins, return on equity and return []

Doximity works on a subscription basis by offering 3 key solutions: marketing, hiring/ HR services, and telehealth.

In the last trading session, 2.75 million shares of the Doximity Inc. (NYSE:DOCS) were traded. Most recently the companys share price was $61.21, and it changed around -$4.26 or -6.51% from the last close, which brings the market valuation of the company to $12.28B. DOCS currently trades at a discount to its 52-week high of Lets Talk About Wall Streets Projection For Doximity Inc. (NYSE: DOCS). Read More »

Doximity (NASDAQ:DOCS) and Cicero (OTCMKTS:CICN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends. Analyst Recommendations This is a breakdown of recent ratings and price targets for Doximity and Cicero, as provided []

Zacks Investment Research upgraded shares of Doximity (NASDAQ:DOCS) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $79.00 target price on the stock. According to Zacks, Doximity Inc. provides digital platform for medical professionals. The companys network members include physicians across all []